CD

Cardiovascular Drugs and Therapy

Cardiovascular Drugs and Therapy is dedicated to the development of cardiovascular drug, device, and cell therapy from bench to bedside. It focuses on advances in hyperlipidemia, diabetes and other cardiometabolic conditions, atherosclerosis, ischemic syndromes, heart failure, cardiomyopathies, valvular heart disease, arrhythmias, mechanisms of action and signaling pathways, new drug development, novel indications for older drugs, genetic approaches to treatment, and new directions in device and cell therapy, interventional and structural heart disease, and cardiac and vascular surgery, as well as guideline-based utilization in real-world patient populations.

Looking to publish in Cardiovascular Drugs and Therapy? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.

Try Livewrite Now
Subject Cardiac & Cardiovascular Systems, Pharmacology & Pharmacy
Impact Factor 3.1
Quartile Q2
Open Access Type Hybrid
ISSN 0920-3206
eISSN 1573-7241
Invitation Only No
Cost Range Open access APC: £3090.00 GBP / $4690.00 USD / €3890.00 EUR; subscription publishing: no APC charges apply.

Submission Instructions

Cardiovascular Drugs and Therapy accepts the following article types. Click on an article type to view submission instructions.

Original Research Articles

Cover Letter Cover Letter requirements are not specified.
Abstract A structured abstract is required. Abstract must be 150 to 250 words long. Abstract must be structured. Abstract must be divided into Purpose, Methods, Results, and Conclusion and include relevant numerical values.
Manuscript Manuscript must not exceed 5000 words excluding figure legends and references. Manuscript must include 4 to 6 keywords, a disclosure statement, a Data Availability Statement explaining access to supporting data including links or citations to publicly archived datasets, documentation of any Large Language Model use in the Methods section or suitable alternative, and a Statements and Declarations or Declarations section including funding, competing interests, and author contributions.
References Reference list must not exceed 50 references. Citations must be numbered in square brackets, references numbered consecutively, all authors listed when there are 6 or fewer authors, the first 3 authors followed by et al. used when there are 6 or more authors, and cited abstracts allowed only if no older than 2 years and marked with [abstr] in the reference list.
Figures & Tables Figures must be provided separately, while figure captions must be included in the manuscript text file. Tables and figures must be numbered in Arabic numerals and cited in consecutive numerical order, each table must include a caption, and each figure must have a concise caption.
Reformat to Cardiovascular Drugs and Therapy using Livewrite Premium

Review Articles

Cover Letter Cover Letter requirements are not specified.
Abstract Abstract is required. Abstract must be 150 to 250 words long. Abstract must be structured. Abstract must be divided into Purpose, Methods, Results, and Conclusion.
Manuscript Review Articles have no fixed length limit and should be presented concisely. Manuscript must include 4 to 6 keywords, documentation of any Large Language Model use in the Methods section or another suitable section if no Methods section is available, a disclosure statement, and a statement specifying who had the idea for the article, who performed the literature search and data analysis, and who drafted or critically revised the work.
References Citations must use numbers in square brackets, references must be numbered consecutively, only cited published or accepted works may appear in the reference list, all authors should be listed for references with 6 or fewer authors, and references with 6 or more authors should list the first 3 authors followed by et al.
Figures & Tables Figures must be provided separately, while figure captions must be included in the manuscript text file. Figures and tables must be numbered with Arabic numerals and cited in the text in consecutive numerical order, each table must have a caption, and each figure must have a concise caption.
Reformat to Cardiovascular Drugs and Therapy using Livewrite Premium

Short Communications

Cover Letter Cover Letter requirements are not specified.
Abstract Abstract is required. Abstract must be 150 to 250 words long. Abstract must be structured. Abstract must be divided into Purpose, Methods, Results, and Conclusion.
Manuscript Manuscript must not exceed 2500 words. Manuscript must include 4 to 6 keywords, document any use of a Large Language Model in the Methods section or another suitable section, and include a Statements and Declarations section with Funding, Competing Interests, and Author Contributions.
References References must not exceed 15. Citations must use a numbered square-bracket style. Reference list entries must be numbered consecutively, include only cited published or accepted works, list all authors when there are 6 or fewer and the first 3 followed by et al. when there are 6 or more, and include full DOI links where available.
Figures & Tables Submission may include up to 2 figures or tables, or one figure and one table. Figures must be provided separately, while figure captions must be included in the manuscript text file. Figures and tables must be numbered with Arabic numerals, cited in consecutive numerical order, and each must have a caption.
Reformat to Cardiovascular Drugs and Therapy using Livewrite Premium

Letters To The Editor

Cover Letter Cover Letter requirements are not specified.
Abstract Abstract requirements are not specified.
Manuscript Letters to the Editor should be less than 1000 words and must not exceed four typed pages.
References Letters to the Editor must not exceed 5 references. Citations must be numbered in square brackets using a numbered reference list style. Reference list entries must be numbered consecutively, list all authors when there are 6 or fewer, and list the first 3 authors followed by et al. when there are 6 or more.
Figures & Tables Letters to the Editor may include one table or one figure. Figures must be provided separately, while figure captions must be included in the manuscript text file.
Reformat to Cardiovascular Drugs and Therapy using Livewrite Premium

Recent Publications

Temporal Coordination of Angiogenic, Nitric Oxide, and Endothelin Pathways in Vascular Adaptation to Hypoxia and Reoxygenation

M. S. Josef

10.1007/s10557-026-07911-5
View Publication

DNA/RNA Methylation-Driven Coronary Microvascular Dysfunction: Emerging Pathogenic Mechanisms and Therapeutic Opportunities for Heart Failure in Diabetes

Ariana Bacelar-Jimenez, Ammar S. Alamareen, Vinuthna Vani Madishetti, Mohammad S. Samarah, Chris J. Watson, David J. Grieve, Karla M. O’Neill

10.1007/s10557-026-07907-1
View Publication

Improving the Cardiorenal Usability of Endothelin Receptor Antagonism in Albuminuric Chronic Kidney Disease: A Testable Role for SGLT2 Inhibitor–based Mitigation of Fluid Retention

Lucas Maciel de Almeida Corrêa, Luiggi Kevin Virgino Brandão, Yan Roberth Delmiro Silva, Guilherme Diniz Ferreira, Nilson Hitoshi Yoshimoto

10.1007/s10557-026-07909-z
View Publication

Complement Component C4B Prioritization Through Drug‒Target Mendelian Randomization and Proteomic Analysis Reveals a Novel Therapeutic Target for Calcific Aortic Valve Stenosis

Weijie Li, Ting Zhou, Songyuan Luo, Jiaohua Chen, Zejia Wu, Wenhui Lin, Xiaolu Hu, Xinyue Yang, Jie Li, Zhaoyan Xu, Jianfang Luo

10.1007/s10557-026-07896-1
View Publication

Sennoside A Ameliorates Myocardial Fibrosis After Myocardial Infarction by Binding to KDM4B and Regulates IRX2 Expression

Yifei Tian, Mengdan Miao, Youlan Lei, Yajuan Yin, Chao Chang, Shuanli Xin, Mingqi Zheng

10.1007/s10557-026-07905-3
View Publication

Frequently asked questions

How long does it take to publish?

All articles are reviewed by two or more referees. Accepted articles are published online after receipt of the corrected proofs.

Reformat to Cardiovascular Drugs and Therapy using Livewrite Premium

Is a cover letter required?

A submission letter is referenced for reviewer suggestions, unpublished material, and transparency on re-use of material.

Reformat to Cardiovascular Drugs and Therapy using Livewrite Premium

What are the publication costs?

Open access APC: £3090.00 GBP / $4690.00 USD / €3890.00 EUR. Subscription publishing has no APC charges.

Reformat to Cardiovascular Drugs and Therapy using Livewrite Premium

Research Topics

Cardiac electrophysiology and arrhythmias Heart Failure Treatment and Management Cardiac Ischemia and Reperfusion Cardiovascular Function and Risk Factors Blood Pressure and Hypertension Studies Lipoproteins and Cardiovascular Health Atrial Fibrillation Management and Outcomes Antiplatelet Therapy and Cardiovascular Diseases Cardiac Imaging and Diagnostics Acute Myocardial Infarction Research Heart Rate Variability and Autonomic Control Cardiac Fibrosis and Remodeling Cardiac Arrhythmias and Treatments Hormonal Regulation and Hypertension Diabetes Treatment and Management Ion channel regulation and function Nitric Oxide and Endothelin Effects Coronary Interventions and Diagnostics Renin-Angiotensin System Studies Diabetes, Cardiovascular Risks, and Lipoproteins Cardiac pacing and defibrillation studies Cardiac Arrest and Resuscitation Atherosclerosis and Cardiovascular Diseases Cardiovascular and exercise physiology Receptor Mechanisms and Signaling

Related Journals

NR
Neuropsychology Review Springer Science+Business Media
AI
Advances in Health Sciences Education Springer Science+Business Media
BE
Biomedical Engineering Letters Springer Science+Business Media
JO
Journal of Molecular and Cellular Cardiology Elsevier BV
EA
Eating and Weight Disorders - Studies on Anorexia Bulimia and Obesity Springer Science+Business Media
B&
Biomolecules & Therapeutics Korean Society of Applied Pharmacology